We hope the concept proposed here may not only inspire further mechanistic studies, but also attempts to target Rad52 in cancer, as a way to selectively induce lethal chromosomal instability in Rad52-dependent cancers, while sparing normal tissues whose genome maintenance does not depend on Rad52. This evidence concerns the gene RAD52 and cancer.